Literature DB >> 7554375

Neutrophil and recombinant myeloperoxidase as antigens in ANCA positive systemic vasculitis.

A K Short1, C M Lockwood, A Bollen, N Moguilevsky.   

Abstract

Myeloperoxidase (MPO) is one of the major autoantigens recognized by anti-neutrophil cytoplasm antibodies. The association of this antigen with specific disease entities requires that there is a source of pure antigen present in large quantities. Further delineation of the molecular mechanisms involved in the antigen-antibody interaction requires the ability to manipulate the molecule. The expression of recombinant MPO in Chinese hamster ovary cells has produced a source of pure protein, suitable for molecular studies. We have shown that this protein is an antigen recognized by 95% of anti-MPO antibodies from patients with systemic vasculitis. This recombinant molecule will be of use in providing an additional specific solid-phase assay for these antibodies and further forms of this protein which mirror the antigenicity of native MPO more exactly may replace chemically purified antigen. It will also be of great value in studies examining the epitopes recognized by anti-MPO antibodies and in studies of immunoregulation and T cell activation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7554375      PMCID: PMC1553337          DOI: 10.1111/j.1365-2249.1995.tb06643.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

1.  Biotin-containing reagents.

Authors:  M Wilchek; E A Bayer
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

2.  Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis: immunodiagnostic value, monoclonal antibodies and characterization of the target antigen.

Authors:  J Lüdemann; E Csernok; M Ulmer; H Lemke; B Utecht; A Rautmann; W L Gross
Journal:  Neth J Med       Date:  1990-04       Impact factor: 1.422

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Abnormal neutrophil myeloperoxidase from a patient with chronic myelocytic leukemia.

Authors:  C L Atkin; M R Andersen; H J Eyre
Journal:  Arch Biochem Biophys       Date:  1982-03       Impact factor: 4.013

5.  An enzyme-linked immunosorbent assay for antibodies to native and denatured DNA.

Authors:  J L Klotz; R M Minami; R L Teplitz
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

6.  Association of IgM with IgG ANCA in patients presenting with pulmonary hemorrhage.

Authors:  V L Esnault; B Soleimani; M T Keogan; A A Brownlee; D R Jayne; C M Lockwood
Journal:  Kidney Int       Date:  1992-05       Impact factor: 10.612

7.  Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models.

Authors:  J E Krawisz; P Sharon; W F Stenson
Journal:  Gastroenterology       Date:  1984-12       Impact factor: 22.682

8.  Site-directed mutants of human myeloperoxidase. A topological approach to the heme-binding site.

Authors:  A Jacquet; V Deleersnyder; L Garcia-Quintana; A Bollen; N Moguilevsky
Journal:  FEBS Lett       Date:  1992-05-11       Impact factor: 4.124

9.  Autoantibodies to lactoferrin and histone in systemic vasculitis identified by anti-myeloperoxidase solid phase assays.

Authors:  V L Esnault; A K Short; M A Audrain; S J Jones; S J Martin; J M Skehel; C M Lockwood
Journal:  Kidney Int       Date:  1994-07       Impact factor: 10.612

10.  Assay method for myeloperoxidase in human polymorphonuclear leukocytes.

Authors:  K Suzuki; H Ota; S Sasagawa; T Sakatani; T Fujikura
Journal:  Anal Biochem       Date:  1983-07-15       Impact factor: 3.365

View more
  4 in total

Review 1.  Methods for the detection of anti-neutrophil cytoplasmic antibodies. Recommendations for clinical use of ANCA serology and laboratory efforts to optimize the informative value of ANCA test results.

Authors:  A Wiik
Journal:  Springer Semin Immunopathol       Date:  2001

Review 2.  Clinical management and treatment of vasculitis.

Authors:  D Jayne
Journal:  Springer Semin Immunopathol       Date:  2001

3.  A panel set for epitope analysis of myeloperoxidase (MPO)-specific antineutrophil cytoplasmic antibody MPO-ANCA using recombinant hexamer histidine-tagged MPO deletion mutants.

Authors:  K Tomizawa; E Mine; A Fujii; Y Y Ohashi; S Yamagoe; Y Hashimoto; A Ishida-Okawara; M Ito; M Tanokura; T Yamamoto; Y Arimura; T Nagasawa; S Mizuno; K Suzuki
Journal:  J Clin Immunol       Date:  1998-03       Impact factor: 8.317

4.  Studies of epitope restriction on myeloperoxidase (MPO), an important antigen in systemic vasculitis.

Authors:  A K Short; C M Lockwood
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.